↓ Skip to main content

Improving Outcomes for Breast Cancer Survivors

Overview of attention for book
Cover of 'Improving Outcomes for Breast Cancer Survivors'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Breast Cancer Survivorship: Where Are We Today?
  3. Altmetric Badge
    Chapter 2 Special Issues in Younger Women with Breast Cancer
  4. Altmetric Badge
    Chapter 3 Special Issues in Older Women with Breast Cancer
  5. Altmetric Badge
    Chapter 4 Breast Cancer Among Special Populations: Disparities in Care Across the Cancer Control Continuum
  6. Altmetric Badge
    Chapter 5 Symptoms: Fatigue and Cognitive Dysfunction
  7. Altmetric Badge
    Chapter 6 Symptoms: Chemotherapy-Induced Peripheral Neuropathy
  8. Altmetric Badge
    Chapter 7 Symptoms: Aromatase Inhibitor Induced Arthralgias
  9. Altmetric Badge
    Chapter 8 Symptoms: Lymphedema
  10. Altmetric Badge
    Chapter 9 Symptoms: Menopause, Infertility, and Sexual Health
  11. Altmetric Badge
    Chapter 10 Host Factors and Risk of Breast Cancer Recurrence: Genetic, Epigenetic and Biologic Factors and Breast Cancer Outcomes.
  12. Altmetric Badge
    Chapter 11 Comorbidities and Their Management: Potential Impact on Breast Cancer Outcomes
  13. Altmetric Badge
    Chapter 12 Modifiable Lifestyle Factors and Breast Cancer Outcomes: Current Controversies and Research Recommendations.
  14. Altmetric Badge
    Chapter 13 Risk Reduction from Weight Management and Physical Activity Interventions
  15. Altmetric Badge
    Chapter 14 Prevention and Treatment of Cardiac Dysfunction in Breast Cancer Survivors.
  16. Altmetric Badge
    Chapter 15 Psychological Adjustment in Breast Cancer Survivors
  17. Altmetric Badge
    Chapter 16 Living with Metastatic Breast Cancer.
  18. Altmetric Badge
    Chapter 17 Quality of Care, Including Survivorship Care Plans.
Attention for Chapter 5: Symptoms: Fatigue and Cognitive Dysfunction
Altmetric Badge

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
64 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Symptoms: Fatigue and Cognitive Dysfunction
Chapter number 5
Book title
Improving Outcomes for Breast Cancer Survivors
Published in
Advances in experimental medicine and biology, January 2015
DOI 10.1007/978-3-319-16366-6_5
Pubmed ID
Book ISBNs
978-3-31-916365-9, 978-3-31-916366-6
Authors

Julienne E. Bower, Patricia A. Ganz, Bower, Julienne E., Ganz, Patricia A.

Abstract

Fatigue and cognitive complaints commonly occur during adjuvant chemotherapy treatment of breast cancer. Fatigue is also associated with radiation therapy, and can occur with surgery alone. Both of these symptoms may persist beyond the initial treatment of breast cancer and they have taken on greater prominence with the growing number of breast cancer survivors. These symptoms are most troublesome when patients try to resume their pre-illness activities (e.g., work, household responsibilities) and find that they are limited. Recovery may take months to years, but in some women these symptoms persist indefinitely and can be very distressing. In this chapter we review what is known about the etiology and biology of these two common symptoms, discuss potential interventions, and describe future research challenges.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 2%
Unknown 63 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 16%
Student > Postgraduate 7 11%
Student > Ph. D. Student 7 11%
Student > Bachelor 5 8%
Researcher 5 8%
Other 14 22%
Unknown 16 25%
Readers by discipline Count As %
Medicine and Dentistry 14 22%
Psychology 11 17%
Nursing and Health Professions 10 16%
Agricultural and Biological Sciences 5 8%
Biochemistry, Genetics and Molecular Biology 2 3%
Other 5 8%
Unknown 17 27%